Sarepta Therapeutics | رأس المال والاحتياطيات



Equity Capital And Reserves تغيير تاريخ
Acadia Pharmaceuticals USD 732.79M 155.61M 2024-12
Agios Pharmaceuticals USD 1.54B 85.72M 2024-12
Alnylam Pharmaceuticals USD 67.09M 34.73M 2024-12
Amgen USD 5.88B 1.65B 2024-12
Biogen USD 16.72B 357.1M 2024-12
BioMarin Pharmaceutical USD 5.66B 244.59M 2024-12
Daiichi Sankyo JPY 1.62T 958M 2025-03
Eli Lilly USD 15.85B 1.65B 2025-03
Gilead Sciences USD 19.33B 856M 2024-12
Incyte USD 3.67B 219.94M 2025-03
Insmed USD 285.38M 198.04M 2024-12
Ionis Pharmaceuticals USD 475.73M 112.62M 2025-03
Moderna USD 10.07B 835M 2025-03
Neurocrine Biosciences USD 2.59B 129.2M 2024-12
Pfizer USD 88.2B 4.08B 2024-12
PTC Therapeutics USD -1098071000 43.72M 2024-12
Regeneron Pharmaceuticals USD 29.39B 34M 2025-03
Roche Holding CHF 36.16B 3.28B 2024-12
Sanofi 74.07B 3.78B 2025-03
Sarepta Therapeutics USD 1.53B 306.67M 2024-12
Tectonic Therapeutic USD 140.78M 9.58M 2024-12
Ultragenyx Pharmaceutical USD 255.3M 91.53M 2024-12
Vertex Pharmaceuticals USD 16.41B 778.7M 2024-12



Sarepta Therapeutics رأس المال والاحتياطيات - القيم الحالية، والبيانات التاريخية، والتنبؤات والإحصاءات والرسوم البيانية والتقويم الاقتصادي - May 2025.